Faraz Ali - Feb 15, 2022 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role: Chief Executive Officer, Director
Signature: /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact
Stock symbol: TNYA
Transactions as of: Feb 15, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/17/2022, 04:45 PM
Previous filing: Jul 29, 2021
Next filing: Feb 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TNYA	Stock Option (Right to buy)	Award	$0	+401K		$0.00	401K	Feb 15, 2022	Common Stock	401K	$15.19	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one (1) month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date.

Content

Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one (1) month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date.